Albany, NY, March 21, 2016 -- The research report, titled “Pharmacovigilance Market (Phases of Drug Development: Preclinical Studies, Clinical Trial Phase I, II, III & IV or Post Marketing Surveillance; Type of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, & EHR Mining; Type of Service: In-House & Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, states that the overall value of the worldwide pharmacovigilance market stood at US$2.4 bn in 2013.
According to the report, the rising incidence of adverse drug reactions and drug toxicity is fueling the demand for pharmacovigilance activities across the world.
For more info, get a Sample PDF: http://www.researchmoz.us/enquiry.php?type=S&repid=479362
The global pharmacovigilance market is segmented on the basis of phase of drug development, method, and service in this research report. Preclinical studies, phase one, phase two, phase three, and post market surveillance are the main phases of drug development. Spontaneous reporting, targeted spontaneous reporting, intensified ADR reporting, cohort event monitoring, and EHR mining are the major methods applied for pharmacovigilance. In-house and contract outsourcing services are the key types of services offered in this market.
On the regional front, the global pharmacovigilance market has been analyzed on the basis of its performance in North America, Asia Pacific, Europe, and the Rest of the World. North America leads the global market among these. In 2013, it accounted for a share of 35% in the overall market. The increase in clinical research activities, coupled with the abundant presence of large-scale research facilities in this region, is the key factor driving the North America pharmacovigilance market.
Asia Pacific, On the other hand, has been anticipated to register the fastest growth at a CAGR of more than 13% during the forecast period. The large pool of skilled workers and the competitive market is likely to fuel the Asia Pacific pharmacovigilance market in the coming years. In addition to this, the rising number of initiatives by various governments in this region, focused on spreading awareness regarding safety and efficiency of drugs, is projected to stimulate the pharmacovigilance market in Asia Pacific extensively over the forecast period, says the market report.
Browse Report description and TOC:
http://www.researchmoz.us/global-pharmacovigilance-industry-2015-market-research-report-report.html
The report states that the global market for pharmacovigilance is highly fragmented in nature. Accenture plc, Clinquest Group B.V., Bristol-Myers Squibb, Cognizant Technology Solutions, F. Hoffmann-La Roche Ltd., Covance Inc., GlaxoSmithKline plc, iGATE Corp., ICON plc, iMEDGlobal Corp., Novartis International AG, inVentiv Health Inc., PAREXEL International Corp., Pharmaceutical Product Development LLC., Pfizer Inc., PRA Health Sciences Inc., Sanofi, Quintiles Transnational Holdings Inc., Wipro Ltd., and Synowledge LLC are the key players operating in the worldwide pharmacovigilance market.
Related Reports:-
Global Pharmacovigilance Market 2014-2020
In terms of regional analysis, the global pharmacovigilance market has been segmented into four key geographies: North America, Europe, Asia Pacific, and Rest of World (RoW). Market revenue estimations for each of these geographies have been provided in the report for the period from 2012 to 2020 in terms of USD million, considering 2013 as the base year for calculations and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations.
Browse Full Report:
About Us
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Mr.Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-621-2074 USA - Canada Toll Free: 866-997-4948 Website: http://www.researchmoz.us/


Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 



